Advertisement

Pharmacy

Home Pharmacy
A Florida stem cell clinic has received a warning letter from the U.S. Food and Drug Administration about what the agency describes as serious problems that could pose health risks to patients.

FDA Cites ‘Significant Deviations’ at Florida Stem Cell Clinic

Agency concerned about 'significant deviations from current good manufacturing practice requirements'
Many non-hormone options and therapies are available for the treatment of estrogen-depletion symptoms in breast cancer survivors

Options Available for Estrogen Depletion After Breast Cancer

Women should be encouraged to optimize lifestyle and should not be treated with hormone therapy
Despite recent improvements in hypertension awareness

Younger Adults, Especially Men, Lag in HTN Treatment, Control

Only four in 10 with the condition get it under control, researchers say
Less than 45 percent of older adults with atrial fibrillation admitted to the hospital are prescribed an anticoagulant

Less Than Half of Seniors With A-Fib Receive Anticoagulants

Increase in overall anticoagulant use over time, mainly due to increase in new oral anticoagulants
Community antibacterial consumption comprises about 85 to 95 percent of total antibacterial consumption

Community Consumption Comprises Most Antibacterial Use

Higher proportion of community consumption in countries with high levels of total consumption
Canakinumab at a dose of 150 mg every three months is associated with reduced rate of cardiovascular events among patients with previous myocardial infarction

Canakinumab 150 mg Tied to Reduced Rate of Cardiac Events

150-mg dose met prespecified threshold for significance for primary and secondary end points
Rivaroxaban plus aspirin is superior to aspirin alone for patients with stable atherosclerotic vascular disease

Rivaroxaban Plus Aspirin Superior for Stable Atherosclerotic Disease

Primary outcome for fewer patients receiving rivaroxaban plus aspirin, but more major bleeding
Use of androgen-deprivation therapy may increase the risk of certain cardiovascular conditions in men with prostate cancer

Androgen-Deprivation Therapy May Carry Cardiovascular Risks

Findings in men with clinically localized prostate cancer initially under active surveillance
Bivalirudin is not associated with a lower rate of the composite of any cause death

No Reduction in Composite End Point for Bivalirudin in PCI

Patients receiving bivalirudin vs heparin saw no reduction in composite of death, MI, major bleeding
For patients with atrial fibrillation who undergo percutaneous coronary intervention

Dual Therapy Noninferior to Triple Therapy for A-Fib With PCI

And lower risk of bleeding with dabigatran and P2Y12 inhibitor dual therapy versus triple therapy